Catalyst Wire Dossier Catalyst Wire Dossier

SA 14-14-2 Japanese Encephalitis Vaccine

Japanese encephalitis vaccine SA-14-14-2 · Chengdu Institute of Biological Products Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SA 14-14-2 Japanese Encephalitis Vaccine, covering 2016-11-29 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of SA 14-14-2 JE Vaccine [Phase 4]

See pricing